Physician profile
Anna Manioudakis
NPI 1952914244
$1,891.82
in general payments reported to CMS, 2019-2025
24 companies · $87.14 in 2025
The $87.14 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $970 · 2022: $633 · 2023: $201 · 2025: $87.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $288.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $484.76 | 2021-2022 | |
| Dexcom, INC. | $302.48 | 2022-2025 | Dexcom G6 Transmitter |
| Amneal Pharmaceuticals LLC | $157.61 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $130.77 | 2021-2023 | |
| Novo Nordisk INC | $96.48 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $86.78 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $82.79 | 2021-2022 | |
| Lilly USA, LLC | $76.53 | 2021 | |
| Abbvie INC. | $74.60 | 2021 | |
| Zealand Pharma US, INC. | $60.93 | 2021-2022 | |
| Corcept Therapeutics | $55.33 | 2021 | |
| Esperion Therapeutics, INC. | $46.26 | 2025 | Nexletol |
| Medtronic, INC. | $33.65 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.66 | 2022 | |
| Mannkind Corporation | $26.80 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $26.74 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.09 | 2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $16.26 | 2023 | Xarelto |
| Pfizer INC. | $15.75 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2022 | |
| Cequr Corporation | $14.07 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.39 | 2022 | |
| Ibsa Pharma INC. | $13.24 | 2021 | |
| Lifescan, INC. | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Manioudakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.